Share Name Share Symbol Market Type Share ISIN Share Description
Aqua Bounty Technologies Inc. LSE:ABTX London Ordinary Share USU0387J1089 COM SHS USD0.001 (REG S)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 12.50p 0.00p 0.00p - - - 0 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -4.6 -3.2 - 19.68

Aqua Bounty (ABTX) Latest News (3)

More Aqua Bounty News
Aqua Bounty Takeover Rumours

Aqua Bounty (ABTX) Share Charts

1 Year Aqua Bounty Chart

1 Year Aqua Bounty Chart

1 Month Aqua Bounty Chart

1 Month Aqua Bounty Chart

Intraday Aqua Bounty Chart

Intraday Aqua Bounty Chart

Aqua Bounty (ABTX) Discussions and Chat

Aqua Bounty Forums and Chat

Date Time Title Posts
20/11/201508:18Aqua Bounty Technologies Inc (could well be a CRACKER)629
23/11/201113:28Aqua Bty Reg S with Charts & News29

Add a New Thread

Aqua Bounty (ABTX) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Aqua Bounty trades in real-time

Aqua Bounty (ABTX) Top Chat Posts

Aqua Bounty Daily Update: Aqua Bounty Technologies Inc. is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker ABTX. The last closing price for Aqua Bounty was 12.50p.
Aqua Bounty Technologies Inc. has a 4 week average price of - and a 12 week average price of -.
The 1 year high share price is - while the 1 year low share price is currently -.
There are currently 157,425,309 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of Aqua Bounty Technologies Inc. is £19,678,163.63.
goz1986: I am not at all upset about the company. I feel they have done everything they can to get approval and reduce the dilution to the share price....... To be fair if I was the Georgian I would be doing the same thing. We are going to be on our knees by December with the begging bowl.
goz1986: If this does get a favourable review from the FDA it is going to be all over the papers which will have a cracking knock on effect on the share price....
bronislav: lufc.what if news comes and its favourable,then there is a demand for shares.where will the share price go/?
goz1986: To raise approximately GBP3.18 million ($5.0 million) before expenses by means of a subscription of 17,666,666 new Common Shares by Linnaeus at a price of 18 pence per share. The Subscription Price represents a 52.6% premium to the volume weighted average share price of the Company for the 90 days ending on the last business day prior to the announcement of the Subscription. I would like to think you don't give 3million to a firm you are concerned will not get permission for a GM slamon.... However, funnier things have happened.
lunartik: Sunday Times The chart shows the share price of Aqua Bounty, a company whose stock is leaping upwards like a salmon heading for its spawning ground. A fitting simile, because Aqua Bounty, headquartered in Massachusetts but listed in London, is making what is likely to be the first genetically modified animal approved for human consumption. Its salmon will grow much faster than a normal one, thanks to the introduction of a gene that keeps growth hormones switched on at all time. Normal salmon take a break every now and then. On Friday, the firm passed another milestone when America's Food and Drug Administration said meat from the modified fish was essentially the same as ordinary salmon. The next big test is a hearing at the end of the month. Meanwhile, in Belgium they are working on the Enviropig - which has less polluting poo - and in America there are bovines that shrug off mad cow disease. Investors face two questions: how do they pick the winners, and how do they gauge public reaction? Protesters are already decrying the "Frankenfish". Shareholders must work out if the likely FDA approval outbalances the risk that the public will say no to buying GM food.
waldron: Aqua Bounty Technolo Aqua Bounty knows no reason for share price fall; still sees 2006 loss in line LONDON (AFX) - Aqua Bounty Technologies Inc said it is unaware of any operational reason for the recent sharp fall in its share price. The biotechnology firm affirmed that its 2006 full-year loss will be in line with expectations, and that it will miss revenue forecasts for 2007, as it had earlier stated in a trading update on March 9. It said its financial health is excellent. In last month's statement, the company said the full-year loss was due to the slow pace of regulatory approval in target markets for its lead product, Shrimp IMS, an immunostimulant deployed as a feed additive. Aqua Bounty will release its results for the year ended Dec 31, 2006 in May. At 8.35 am, shares in Aqua Bounty were up 1/2 pence at 30-1/2, having fallen from around 83 pence at the beginning of March. The company floated on AIM in March last year at 148 pence. ukn/pmi/ak
Aqua Bounty share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V: D:20161024 21:54:32